Literature DB >> 9741403

Single muscle fiber analysis in patients with 3243 mutation in mitochondrial DNA: comparison with the phenotype and the proportion of mutant genome.

M Ozawa1, I Nonaka, Y Goto.   

Abstract

An A-to-G point mutation at nucleotide pair (np) 3243 (3243 mutation) in mitochondrial DNA (mtDNA) is a well-known pathogenic mutation, which has been found in approximately 80% of patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). It has been reported that the 3243 mutation also occurs in individuals with non-MELAS phenotypes. The reasons for the phenotypic heterogeneity of the 3243 mutation have not been clarified, although it may be closely related with mtDNA heteroplasmy and their differing proportions in different tissues. We examined the proportion of mutant DNA in muscle specimens at the cellular level using single fiber analysis in five patients with the 3243 mutation: three were diagnosed clinically as having MELAS and two had mitochondrial diabetes mellitus (MDM). In both phenotypes, ragged-red fibers (RRF) contained a higher percentage of mutant DNA (average 89.8%) than non-RRF (average 42.4%). On the other hand, the proportion of mutant DNA in non-RRF revealed a wider range than in RRF and the average was higher in MELAS patients (58.5+/-27.3%) than that in MDM patients (26.3+/-27.9%), which correlated with biochemical and morphological mitochondrial abnormalities in muscle. These findings may reflect the underlying mechanisms of tissue specificity in each phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741403     DOI: 10.1016/s0022-510x(98)00152-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Maternally inherited deafness and unusual phenotypic manifestations associated with A3243G mitochondrial DNA mutation.

Authors:  Katalin Komlósi; Richárd Kellermayer; Anita Maász; Viktória Havasi; Katalin Hollódy; Olga Vincze; Hajnalka Merkli; Endre Pál; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

Review 2.  Clinical and molecular studies of mitochondrial disease.

Authors:  Y Goto
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions.

Authors:  Rafik Z Fayzulin; Michael Perez; Natalia Kozhukhar; Domenico Spadafora; Glenn L Wilson; Mikhail F Alexeyev
Journal:  Nucleic Acids Res       Date:  2015-03-27       Impact factor: 16.971

4.  Anti-replicative recombinant 5S rRNA molecules can modulate the mtDNA heteroplasmy in a glucose-dependent manner.

Authors:  Romuald Loutre; Anne-Marie Heckel; Damien Jeandard; Ivan Tarassov; Nina Entelis
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 5.  The molecular pathology of pathogenic mitochondrial tRNA variants.

Authors:  Uwe Richter; Robert McFarland; Robert W Taylor; Sarah J Pickett
Journal:  FEBS Lett       Date:  2021-02-12       Impact factor: 3.864

Review 6.  Mitochondrial DNA disorders: from pathogenic variants to preventing transmission.

Authors:  Tiago M Bernardino Gomes; Yi Shiau Ng; Sarah J Pickett; Doug M Turnbull; Amy E Vincent
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.